Company Focus

Icon

Latest Icon News

Survey shows varied views on impact of new cancer drugs
Pharmaceutical
As the world’s leading cancer research professionals arrived at the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona on Friday, they were given a reminder of some of the remaining challenges that lie ahead in their field.   13 September 2024


Insights

Company Spotlight

Latest News & Features of interest to Icon

Latest In Brief for Icon

Biotechnology
Japan’s Eisai and US partner Biogen have announced today update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab (trade name Leqembi) as a treatment for early mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD) in the European Union.   3 February 2025

Latest Relevant Ones To Watch News

Relevant Ones to Watch Companies

Reset all filters
Refine Search